Regional/Local Meetings

Intensive Care/Critical Care Medicine - Curriculum-Based Online and Live Activities

Improving the Diagnosis, Treatment, and Outcomes of Patients With HAP and VAP: A Critical Look at Current Guidelines and New Treatment Options

Andrew F. Shorr, MD, MPH, MBA, FACP, FCCP
MedStar Washington Hospital Center
Georgetown University
Washington, District of Columbia

Oncology - Practice/Institution-Based Meetings

Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors

Robert Coleman, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

Respirology/Pulmonology - Practice/Institution-Based Meetings

Applying New Insights to Improve Diagnosis and Management of Interstitial Lung Diseases

Amy L. Olson, MD, MSPH
National Jewish Health
Denver, Colorado

Hematology-Oncology - Practice/Institution-Based Meetings

Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics

Robert Z. Orlowski, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Rheumatology - AAFP Chapter Meetings

Axial Spondyloarthritis: A Case-Based Approach to Addressing Diagnostic Challenges and Missed Opportunities in the Primary Care Setting

Leonard H. Calabrese, DO
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, Ohio

Oncology - ONS Chapter Meetings

Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma: Practical Issues and Evidence for the Front-Lines of Care

Amy Goodrich, NP
The Johns Hopkins Kimmel Cancer Center
Baltimore, Maryland

Emergency Medicine - Regional/Local Meetings

Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED

Evan J. Lipson, MD
Johns Hopkins University School of Medicine
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Emergency-Medicine - ACEP Chapter Meetings

Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department

Daniel Pallin, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital
Boston, Massachusetts

Pathology - Pathology Chapter Meetings

Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do

Lynette M. Sholl, MD
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

Oncology - Pathology Chapter Meetings

The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy

Anna F. Farago, MD, PhD
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Oncology - Practice/Institution-Based Meetings

Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations

Mark A. Socinski, MD
Florida Hospital Cancer Institute
Orlando, Florida

Hematology-Oncology - Practice/Institution-Based Meetings

Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies

Nathan H. Fowler, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

Hematology - Practice/Institution-Based Meetings

Treatment Innovation in Hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice

Mark T. Reding, MD
University of Minnesota
Minneapolis, Minnesota

Oncology - AUA State Chapter Meetings

Unraveling the Complex Treatment Landscape of Prostate Cancer: Guidance for Delivering Evidence-Based, Patient-Centered Care

Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina